2025 ESMO West
Learn How to Claim Your Credit
The European Society for Medical Oncology (ESMO) and Total Health partnered to expand access in the US to the latest developments in the management of cancer from our European colleagues. This free conference covers highlights from the ESMO Congress 2025, equipping healthcare providers with the latest strategies to improve clinical practice and treatment outcomes in cancer care. The accredited meeting will be hosted as an in-person conference.
Accreditation Information | 8.00
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Amedco LLC designates this activity for a maximum of 8.0 ANCC contact hours.
-
Amedco LLC designates this live activity for a maximum of 8.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
-
Amedco LLC designates this activity for a maximum of 8.0 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
-
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. If you need MOC credit, you also need to pass a posttest with a score of at least 80%. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferences. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Professions in scope for this activity are listed below.
Amedco Joint Accreditation Provider Number: 4008163
Physicians
Amedco LLC designates this live activity for a maximum of 7.25 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists & Pharmacy Technicians
Amedco LLC designates this activity for a maximum of 7.25 knowledge-based CPE contact hours. JA4008163-9999-25-239-L01-P | JA4008163-9999-25-239-L01-T
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
Nurses
Amedco LLC designates this activity for a maximum of 7.25 ANCC contact hours.
American Board of Internal Medicine (ABIM) MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
You must request your certificate within 45 days of the activity to meet the deadline for submission to PARS. Credits are generally reported during the first week of each month for those who claimed during the month prior.
Learner Notification Objectives - After Attending This Program You Should Be Able To
1. Employ an understanding of personalized medicine to individualize the use of available drugs for lung cancers, gastrointestinal cancers, breast cancers, genitourinary cancers, and hematological malignancies. Communicate the efficacy and safety of the drugs discussed in the case studies and other emerging treatments for lung cancers, gastrointestinal cancers, breast cancers, genitourinary cancers, and hematological malignancies.
2. Understand the emerging and standard diagnostic tests used to assist in planning therapy for lung cancers, gastrointestinal cancers, breast cancers, genitourinary cancers, and hematological malignancies. Formulate management strategies, considering the contributory roles of local and systemic therapy.
3. Recall the design of ongoing clinical trials evaluating novel investigational agents and counsel appropriately selected patients about availability and participation.
Disclosure of Conflict of Interest The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5) All individuals in a position to control the content of CE are listed below. Name Commercial Interest: Relationship
Thierry Alcindor NA
Steven Bair Kura Oncology, Syndax:Consultant
manojkumar bupathi NA
Ezra Cohen Tempus AI:Employee
Kyle Concannon Boeringher Ingelheim:Consultant
Liat Dagan NA
Gary Doolittle Iovance:Scientific/Medical Advisory Board Member
Anthony Elias NA
Abhijeet Kumar ADC therapeutics:Consultant Incyte:Speakers Bureau
Michael Lattanzi Merck, Aveo, Pfizer, Johnson & Johnson, Aadi:Consultant Exelixis, Aveo, Astrazeneca, EMD Serono, Pfizer, Merck, Johnson & Johnson:Speakers Bureau
Christopher Lieu Genentech, Merck, Janssen:Research Grant Site Principal Investigator
Eric Liu NA
Christine McMahon Kura Oncology, Syndax Pharmaceuticals:Scientific/Medical Advisory Board Member Johnson and Johnson:Consultant
Julie Messina NA
Tejas Patil Nuvation, Bristol-Myers Squibb, Summit Therapeutics, Pfizer, Astrazeneca, Regeneron, Guardant, Boehringer Ingelheim, Takeda:Scientific/Medical Advisory Board Member Johnson & Johnson:Research Grant Overall Principal Investigator Gilead:Research Grant Site Principal Investigator
Lee Schwartzberg AstraZeneca, Napo, GlaxoSmithKline, Pfizer, Helsinn, Novartis, Spectrum, Daiichi Sankyo:Consultant Agendia, Foundation Medicine, Merck:Speakers Bureau
Urs Weber Janssen Biotech:Consultant
Reyna Wilhelm NA
Justin Kaiser NA
How to Get Your Certificate
1. Go to thc.cmecertificateonline.com
2. Click on the ESMO USA West link.
3. For ABIM MOC click on the ESMO USA West ABIM MOC link.
4. Evaluate the meeting.
5. Print, download, or save your certificate for your records.
6. If you lose your certificate, or need help, go to help.cmecertificateonline.com
How to Get Your Certificate
Go to thc.cmecertificateonline.com
Evaluate the meeting.
Print, download, or save your certificate for your records.
If you lose your certificate, or need help, go to help.cmecertificateonline.com